Etidronate Disodium

CAS 7414-83-7 6 FDA-DMF suppliersSmall Molecule

Overview

Etidronate disodium is a bisphosphonate used in the treatment of conditions characterized by abnormal bone resorption, such as osteoporosis and Paget's disease. It works by inhibiting osteoclast-mediated bone resorption, thus modulating bone metabolism.

API suppliers (3)

Suppliers of Etidronate Disodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • MEDICHEM SASpain
  • BOMBAY DRUGS AND PHARMAS LTD
  • VIS FARMACEUTICI INSTITUTO SCIENTIFICO VINEZIE SPA

Therapeutic areas

OsteoporosisPaget's DiseaseHypercalcemia

Related APIs

Risedronate Sodium
7 suppliers
Pamidronate Disodium
4 suppliers
Zoledronic Acid
25 suppliers
Teriparatide
14 suppliers
Raloxifene Hydrochloride
11 suppliers
Alendronate Sodium
8 suppliers
Ibandronate Sodium
5 suppliers
Bazedoxifene Acetate
5 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo